Study Title
An Open-label, Prospective, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Ablative Radioembolization Using Yttrium-90 Glass Microspheres in Patients With Locally-advanced Hepatocellular Carcinom
Study Details
Description:
The RESOLVE trial, an open-label, single-arm, multi-center study, aims to assess the efficacy and safety of ablative radioembolization using TheraSphere Yttrium-90 microspheres. This trial specifically targets patients diagnosed with hepatocellular carcinoma accompanied by localized portal vein tumor thrombosis (Vp1-Vp3) and who maintain good liver function.
Sponsor:
Seoul National University Hospital
Contacts:
Jin Woo Choi, MD, PhD (Principal Investigator)jwchoi.med@snu.ac.kr
+82-220722584
Government Study Link:
NCT06166576 - Click here to see study onClinicalTrials.gov